SCHEMBL2170080

SCHEMBL2170080

O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)C1CC(Cc2ccccc2)CN1C(=O)Cn1cncn1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 9/20 1.00
CYP2C9 P11712 6/20 1.00
CYP2D6 P10635 6/20 1.00
CYP3A4 P08684 3/20 0.92
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
KMT2A Q03164 1/20 0.37
FAAH O00519 1/20 0.37
CFTR P13569 1/20 0.37
CYP19A1 P11511 1/20 0.35
MC4R P32245 1/20 0.35
MC3R P41968 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1373685 1.00 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4MEN1
SCHEMBL1374243 0.96 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL1374743 0.96 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL2171064 0.96 S1PR1 (1.00) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL1373052 0.93 S1PR1 (0.87) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL2170136 0.93 S1PR1 (0.87) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL12024932 0.92 S1PR1 (0.92) S1PR1CYP2C9CYP2D6CYP3A4POLB
SCHEMBL1372429 0.92 S1PR1 (0.85) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL2362712 0.92 S1PR1 (0.85) S1PR1CYP2C9CYP2D6CYP3A4FAAH
SCHEMBL2362711 0.92 S1PR1 (0.85) S1PR1CYP2C9CYP2D6CYP3A4FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 EP disclosed
WO-2010045580-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed